Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Thornton

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 12, 2007
Distinctive immunoglobulin E anti-house dust allergen-binding specificities in a tropical Australian Aboriginal communityB J Hales, I A Laing, L J Pearce, et al.
Cancer Biology & Therapy|June 7, 2008
Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude miceEkaterina Dadachova, E Revskaya, M A Sesay, et al.
Infection and Immunity|January 23, 2020
Nasal Delivery of a Commensal <i>Pasteurellaceae</i> Species Inhibits Nontypeable Haemophilus influenzae Colonization and Delays Onset of Otitis Media in MiceCaitlyn M Granland, Naomi M Scott, Jean-Francois Lauzon-Joset, et al.
Infection and Immunity|May 24, 2005
Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trialGiane A Oliveira, Kristiane Wetzel, J Mauricio Calvo-Calle, et al.
Scientific Reports|April 5, 2018
Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapyJ D Nosanchuk, A Jeyakumar, A Ray, et al.
BMC Pulmonary Medicine|April 4, 2019
Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in childrenMejbah U Bhuiyan, Christopher C Blyth, Rachel West, et al.
Thorax|October 20, 2018
The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case<b>-</b>control studyMejbah Uddin Bhuiyan, Thomas L Snelling, Rachel West, et al.
Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.
Clinical Pharmacology and Therapeutics|December 13, 2016
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3AT Prueksaritanont, D A Tatosian, X Chu, et al.
The Journal of Infection|September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 12, 2007
Distinctive immunoglobulin E anti-house dust allergen-binding specificities in a tropical Australian Aboriginal communityB J Hales, I A Laing, L J Pearce, et al.
Cancer Biology & Therapy|June 7, 2008
Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude miceEkaterina Dadachova, E Revskaya, M A Sesay, et al.
Infection and Immunity|January 23, 2020
Nasal Delivery of a Commensal <i>Pasteurellaceae</i> Species Inhibits Nontypeable Haemophilus influenzae Colonization and Delays Onset of Otitis Media in MiceCaitlyn M Granland, Naomi M Scott, Jean-Francois Lauzon-Joset, et al.
Infection and Immunity|May 24, 2005
Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trialGiane A Oliveira, Kristiane Wetzel, J Mauricio Calvo-Calle, et al.
Scientific Reports|April 5, 2018
Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapyJ D Nosanchuk, A Jeyakumar, A Ray, et al.
BMC Pulmonary Medicine|April 4, 2019
Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in childrenMejbah U Bhuiyan, Christopher C Blyth, Rachel West, et al.
Thorax|October 20, 2018
The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case<b>-</b>control studyMejbah Uddin Bhuiyan, Thomas L Snelling, Rachel West, et al.
Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.
Clinical Pharmacology and Therapeutics|December 13, 2016
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3AT Prueksaritanont, D A Tatosian, X Chu, et al.
The Journal of Infection|September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Pageof 23